Clinical Trial Update: Alternate Dosing Schedules Study for HPV Vaccine (ADS)

View source ↗

Summary

A completed clinical trial update for the Alternate Dosing Schedules Study for the HPV vaccine (ADS) sponsored by Duke University, evaluating alternate dosing s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Genital Warts

Drugs mentioned

• HPV Vaccine (ADS) (human papillomavirus vaccine)

Snippet

Sponsor: Duke University | Conditions: Cervical Cancer, Genital Warts | Status: COMPLETED